NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has announced the appointment of Christopher Cleary as an ...
CMOs can solve challenges with state-of-the-art equipment and expertise, explains Henri Asselin at Beacon MedTech Solutions.
Pro Medicus is in a strong financial position. As of June 2024, it had AUD 155 million in net cash, and we forecast the company to continue holding net cash over our explicit 10-year forecast period.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback